InvestorsHub Logo

bigfred1

07/10/19 12:00 AM

#3192 RE: sorkin #3191

for some reason i think the opposite. I am thinking closer to 10.

Teva said in May it expected to reach around 20% market share by the end of the second quarter and could approach 50% market share by the end of the year. (Reporting by Aakash Jagadeesh Babu and Tamara Mathias in Bengaluru and Michael Erman in New York; Editing by Maju Samuel and Bill Berkrot)

This came out in fidelity today and it is about EpiPEN FOR ALLERGIS...There is a big shortage.